| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.072 | 0.09 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.054 | 0.3 |